These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16219306)
21. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease. Pietropaolo S; Feldon J; Yee BK Behav Neurosci; 2008 Aug; 122(4):733-47. PubMed ID: 18729626 [TBL] [Abstract][Full Text] [Related]
22. Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Deters N; Ittner LM; Götz J Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339 [TBL] [Abstract][Full Text] [Related]
23. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia. García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255 [TBL] [Abstract][Full Text] [Related]
24. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Kraemer BC; Burgess JK; Chen JH; Thomas JH; Schellenberg GD Hum Mol Genet; 2006 May; 15(9):1483-96. PubMed ID: 16600994 [TBL] [Abstract][Full Text] [Related]
25. [Animal models of tauopathies]. Higuchi M Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223 [TBL] [Abstract][Full Text] [Related]
26. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756 [TBL] [Abstract][Full Text] [Related]
27. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695 [TBL] [Abstract][Full Text] [Related]
28. 3R tau expression modifies behavior in transgenic mice. Shiryaev N; Jouroukhin Y; Gozes I J Neurosci Res; 2010 Sep; 88(12):2727-35. PubMed ID: 20544828 [TBL] [Abstract][Full Text] [Related]
29. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice. Fukushima T; Nakamura A; Iwakami N; Nakada Y; Hattori H; Hoki S; Yamaguchi H; Nakagawa M; Terashima N; Narita H Biochem Biophys Res Commun; 2011 Apr; 407(4):730-4. PubMed ID: 21439944 [TBL] [Abstract][Full Text] [Related]
30. Substrate-specific reduction of PP2A activity exaggerates tau pathology. Deters N; Ittner LM; Götz J Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401 [TBL] [Abstract][Full Text] [Related]
31. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Hrnkova M; Zilka N; Minichova Z; Koson P; Novak M Brain Res; 2007 Jan; 1130(1):206-13. PubMed ID: 17169350 [TBL] [Abstract][Full Text] [Related]
32. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells. Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282 [TBL] [Abstract][Full Text] [Related]
33. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice. Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748 [TBL] [Abstract][Full Text] [Related]
34. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644 [TBL] [Abstract][Full Text] [Related]
35. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. Vulih-Shultzman I; Pinhasov A; Mandel S; Grigoriadis N; Touloumi O; Pittel Z; Gozes I J Pharmacol Exp Ther; 2007 Nov; 323(2):438-49. PubMed ID: 17720885 [TBL] [Abstract][Full Text] [Related]
36. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269 [TBL] [Abstract][Full Text] [Related]
37. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818 [TBL] [Abstract][Full Text] [Related]
38. Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy. Chiba S; Takada E; Tadokoro M; Taniguchi T; Kadoyama K; Takenokuchi M; Kato S; Suzuki N Neurobiol Aging; 2012 Oct; 33(10):2491-505. PubMed ID: 22169201 [TBL] [Abstract][Full Text] [Related]
39. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model. Yoshiyama Y; Uryu K; Higuchi M; Longhi L; Hoover R; Fujimoto S; McIntosh T; Lee VM; Trojanowski JQ J Neurotrauma; 2005 Oct; 22(10):1134-41. PubMed ID: 16238489 [TBL] [Abstract][Full Text] [Related]
40. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice. Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]